Evidence map›Paper›PMID 29119134›Full record

ArticleNPJ breast cancer2017

Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.

Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, Joseph Vijai, Susan L Neuhausen, Steve N Hart, Vignesh Ravichandran, Tinu Thomas, Ann Maria, Danylo Villano and 17 more

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in NPJ breast cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 13 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 12 institutions in 3 countries.

Thomas P Slavin *Department of Medical Oncology, Division of Clinical Cancer Genetics, City of Hope, Duarte, CA USA.
Kara N Maxwell *Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA USA.
Jenna Lilyquist *Department of Health Sciences Research, Mayo Clinic, Rochester, MN USA.
Joseph Vijai *Clinical Genetics Research Lab, Department of Medicine and Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY USA.
Susan L NeuhausenDepartment of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA USA.
Steve N HartDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN USA.
Vignesh RavichandranClinical Genetics Research Lab, Department of Medicine and Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY USA.
Tinu ThomasClinical Genetics Research Lab, Department of Medicine and Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY USA.
Ann MariaClinical Genetics Research Lab, Department of Medicine and Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY USA.
Danylo VillanoClinical Genetics Research Lab, Department of Medicine and Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY USA.
Kasmintan A SchraderDepartment of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC Canada.
Raymond MooreDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN USA.
Chunling HuDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN USA.
Bradley WubbenhorstDepartment of Medicine, Division of Translational Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA USA.
Brandon M WenzDepartment of Medicine, Division of Translational Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA USA.
Kurt D'AndreaDepartment of Medicine, Division of Translational Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA USA.
Mark E RobsonClinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA.
Paolo PeterlongoIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Bernardo BonanniDivision of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy.
James M FordDivision of Oncology, Stanford University School of Medicine, Stanford, CA USA.
Judy E GarberCenter for Cancer Genetics and Prevention, Dana Farber Cancer Institute, Boston, MA USA.
Susan M DomchekDepartment of Medicine, Division of Hematology-Oncology, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA USA.
Csilla SzaboNational Institutes of Health, Bethesda, MD USA.
Kenneth OffitClinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA.
Katherine L NathansonAbramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA USA.
Jeffrey N WeitzelDepartment of Medical Oncology, Division of Clinical Cancer Genetics, City of Hope, Duarte, CA USA.
Fergus J CouchDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN USA.
Memorial Sloan Kettering Cancer Center · USUniversity of Pennsylvania · USMayo Clinic in Florida · USCity of Hope · USBC Cancer Agency · CABeckman Research InstituteCancer Genetics (United States) · USEuropean Institute of Oncology · ITFIRC Institute of Molecular Oncology · ITMayo Clinic in Arizona · USNational Institutes of Health · USStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1038/s41523-017-0024-8.].

Identifiers

PMID29119134
PMCPMC5673936
OpenAlexW2768048855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.